Suppose 226 subjects are treated with a drug that is used to treat pain and 54 of them developed nausea. Use a 0.10 significance level to test the claim that more than 20% of users develop nausea. Identify the null and alternative hypotheses for this test. Choose the correct answer below. O A. Ho: p=0.20 H₁: p<0.20 OB. Ho: p>0.20 H₁: p=0.20 O C. Ho: p=0.20 H₁: p>0.20 O D. Ho: p=0.20 H₁: p0.20 Identify the test statistic for this hypothesis test. The test statistic for this hypothesis test is (Round to two decimal places as needed.) Identify the P-value for this hypothesis test. The P-value for this hypothesis test is. (Round to three decimal places as needed.) Identify the conclusion for this hypothesis test. O A. Fail to reject Ho. There is not sufficient evidence to warrant support of the claim that more than 20% of users develop nausea. B. Reject Ho. There is sufficient evidence to warrant support of the claim that more than 20% of users develop nausea.

Holt Mcdougal Larson Pre-algebra: Student Edition 2012
1st Edition
ISBN:9780547587776
Author:HOLT MCDOUGAL
Publisher:HOLT MCDOUGAL
Chapter11: Data Analysis And Probability
Section: Chapter Questions
Problem 8CR
icon
Related questions
Question
Suppose 226 subjects are treated with a drug that is used to treat pain and 54 of them developed
nausea. Use a 0.10 significance level to test the claim that more than 20% of users develop
nausea.
Identify the null and alternative hypotheses for this test. Choose the correct answer below.
O A. Ho: p=0.20
H₁: p<0.20
B. Ho:p>0.20
H₁: p=0.20
C. Ho: p=0.20
H₁: p>0.20
D. Ho: p=0.20
H₁: p=0.20
Identify the test statistic for this hypothesis test.
The test statistic for this hypothesis test is
(Round to two decimal places as needed.)
Identify the P-value for this hypothesis test.
The P-value for this hypothesis test is
(Round to three decimal places as needed.)
Identify the conclusion for this hypothesis test.
O A. Fail to reject Ho. There is not sufficient evidence to warrant support of the claim that more
than 20% of users develop nausea.
B. Reject Ho. There is sufficient evidence to warrant support of the claim that more than 20%
of users develop nausea.
C. Fail to reject Ho. There is sufficient evidence to warrant support of the claim that more than
20% of users develop nausea.
D. Reject Ho. There is not sufficient evidence to warrant support of the claim that more than
20% of users develop nausea.
Transcribed Image Text:Suppose 226 subjects are treated with a drug that is used to treat pain and 54 of them developed nausea. Use a 0.10 significance level to test the claim that more than 20% of users develop nausea. Identify the null and alternative hypotheses for this test. Choose the correct answer below. O A. Ho: p=0.20 H₁: p<0.20 B. Ho:p>0.20 H₁: p=0.20 C. Ho: p=0.20 H₁: p>0.20 D. Ho: p=0.20 H₁: p=0.20 Identify the test statistic for this hypothesis test. The test statistic for this hypothesis test is (Round to two decimal places as needed.) Identify the P-value for this hypothesis test. The P-value for this hypothesis test is (Round to three decimal places as needed.) Identify the conclusion for this hypothesis test. O A. Fail to reject Ho. There is not sufficient evidence to warrant support of the claim that more than 20% of users develop nausea. B. Reject Ho. There is sufficient evidence to warrant support of the claim that more than 20% of users develop nausea. C. Fail to reject Ho. There is sufficient evidence to warrant support of the claim that more than 20% of users develop nausea. D. Reject Ho. There is not sufficient evidence to warrant support of the claim that more than 20% of users develop nausea.
Expert Solution
steps

Step by step

Solved in 2 steps

Blurred answer
Recommended textbooks for you
Holt Mcdougal Larson Pre-algebra: Student Edition…
Holt Mcdougal Larson Pre-algebra: Student Edition…
Algebra
ISBN:
9780547587776
Author:
HOLT MCDOUGAL
Publisher:
HOLT MCDOUGAL
College Algebra (MindTap Course List)
College Algebra (MindTap Course List)
Algebra
ISBN:
9781305652231
Author:
R. David Gustafson, Jeff Hughes
Publisher:
Cengage Learning